Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
D01AC12,G01AF12
CAS registry number (Chemical Abstracts Service)
0072479-26-6
Chemical Formula
C24-H20-Cl2-N2-O-S
Molecular Weight
455
Therapeutic Category
Antifungal agent
Chemical Name
1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-[[4-(phenylthio)phenyl]methoxy]ethyl]-
Foreign Names
- Fenticonazolum (Latin)
- Fenticonazol (German)
- Fenticonazole (French)
- Fenticonazol (Spanish)
Generic Names
- Fenticonazole (OS: DCF, BAN)
- Fenticonazolo (OS: DCIT)
- Fenticonazole Nitrate (OS: BANM, USAN)
- Rec 15/1476 (IS: Recordati)
- Fenticonazole (nitrate de) (PH: Ph. Eur. 6)
- Fenticonazole Nitrate (PH: BP 2010, Ph. Eur. 6)
- Fenticonazoli nitras (PH: Ph. Eur. 6)
- Fenticonazolnitrat (PH: Ph. Eur. 6)
Brand Names
- Lomexin
Algorithm, Oman; Pharmaplan, South Africa; Recordati, Taiwan - Falvin
Recordati, Italy - Fenizolan
Merckle Recordati, Germany - Fentikol
Zorka, Serbia - Fentizol
Aché, Brazil - Gyno-Lomexin
Organon, Turkey; Recordati, Luxembourg - Gynoxin
Organon, Luxembourg; Recordati, Poland - Laurimic Vaginal
Effik, Spain - Laurimic
Effik, Spain - Lomexin Vaginal
Recordati, Spain - Lomexin
Altana, Brazil; Altana, Mexico; Decafarma, Portugal; Effik, France; Fournier, Romania; Galenica, Greece; Gerot, Austria; Merckle Recordati, Germany; Orivas, Latvia; Pierre Fabre Medicament, Slovakia; Recordati, Bulgaria; Recordati, Czech Republic; Recordati, Spain; Recordati, Italy; Recordati, Lithuania; Recordati, Serbia; Recordati, Vietnam - Lorenil
Effik, Italy - Terlomexin
Effik, France
International Drug Name Search
Glossary
BAN | British Approved Name |
BANM | British Approved Name (Modified) |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment